Cargando…
Molecular targets of luteolin in cancer
Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses ex...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885545/ https://www.ncbi.nlm.nih.gov/pubmed/25714651 http://dx.doi.org/10.1097/CEJ.0000000000000128 |
_version_ | 1782434521754370048 |
---|---|
author | Tuorkey, Muobarak J. |
author_facet | Tuorkey, Muobarak J. |
author_sort | Tuorkey, Muobarak J. |
collection | PubMed |
description | Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses existing data on luteolin’s anticancer activities and then offers possible explanations for and molecular targets of its cancer-preventive action. Luteolin prevents tumor development largely by inactivating several signals and transcription pathways essential for cancer cells. This review also offers insights into the molecular mechanisms and targets through which luteolin either prevents cancer or mediates cancer cell death. |
format | Online Article Text |
id | pubmed-4885545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-48855452016-06-15 Molecular targets of luteolin in cancer Tuorkey, Muobarak J. Eur J Cancer Prev Review Article: Carcinogenesis Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses existing data on luteolin’s anticancer activities and then offers possible explanations for and molecular targets of its cancer-preventive action. Luteolin prevents tumor development largely by inactivating several signals and transcription pathways essential for cancer cells. This review also offers insights into the molecular mechanisms and targets through which luteolin either prevents cancer or mediates cancer cell death. Lippincott Williams & Wilkins 2016-01 2015-12-02 /pmc/articles/PMC4885545/ /pubmed/25714651 http://dx.doi.org/10.1097/CEJ.0000000000000128 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. |
spellingShingle | Review Article: Carcinogenesis Tuorkey, Muobarak J. Molecular targets of luteolin in cancer |
title | Molecular targets of luteolin in cancer |
title_full | Molecular targets of luteolin in cancer |
title_fullStr | Molecular targets of luteolin in cancer |
title_full_unstemmed | Molecular targets of luteolin in cancer |
title_short | Molecular targets of luteolin in cancer |
title_sort | molecular targets of luteolin in cancer |
topic | Review Article: Carcinogenesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885545/ https://www.ncbi.nlm.nih.gov/pubmed/25714651 http://dx.doi.org/10.1097/CEJ.0000000000000128 |
work_keys_str_mv | AT tuorkeymuobarakj moleculartargetsofluteolinincancer |